Vanta Bioscience Limited (VANTABIO.BO) AI-Powered Stock Analysis
See how Vanta Bioscience Limited scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
VANTABIO.BO●BSE
HealthcareBiotechnology
₹24.09
₹1.26(4.97%)
Indian Market opens in 49h 10m
Advertisement
Vanta Bioscience Limited (VANTABIO.BO)
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerVanta Bioscience Limited (VANTABIO.BO) Stock Overall Grade
Vanta Bioscience Limited’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Vanta Bioscience Limited's overall stock rating.
Forecast
BScore
61/100Financial Growth
CScore
40/100Fundamental Growth
DScore
37/100Key Ratios
CScore
45/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
98/100Analyst Consensus
C+Score
50/100Vanta Bioscience Limited (VANTABIO.BO) AI-Powered Stock Analysis
This asset demonstrates Normal performance with an overall Forecast Score of 61/100 (B), reflecting high confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (37/100, D) highlight its stability, while Key Ratios (45/100, C) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (98/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Vanta Bioscience Limited stock grade, including financials, comparisons, and forecasts.